US-based, Prospective, Blinded Study of Thyrotropin Receptor Antibody in Autoimmune Thyroid Disease
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgae448 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Mark A Lupo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Thyroid & Endocrine Center of Florida, Sarasota, FL 34239, USA. Hauptthemen laut MEDLINE: Receptors, Thyrotropin, Autoantibodies, Thyroiditis, Autoimmune, Thyroid Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: QuidelOrtho Corp.
Abstract (Originalsprache)
Context
Bioassays provide information on the functionality of thyrotropin receptor antibodies (TSH-R-Ab) and thus may offer more clinical utility than binding assays.
Objective
In this prospective, blinded, US-based study, the clinical performance of several TSH-R-Ab assays was compared.
Setting
US endocrinology clinic. Subjects One hundred sixty-two unselected, consecutive, well-documented patients with various thyroid diseases and healthy controls. Intervention(s) Blinded TSH-R-Ab measurements. Main Outcome Measure(s) Sensitivity and specificity of 4 TSH-R-Ab assays.
Results
The 4 TSH-R-Ab assays were negative in all 42 patients without autoimmune thyroid disease (AITD). In 104 patients with Graves’ disease (GD), irrespective of the disease duration, TSH-R-Ab positivity was present in 65 (63%), 67 (65%), and 87 (84%) for the Cobas and Immulite binding assays and stimulatory TSH-R-Ab [thyroid-stimulating immunoglobin (TSI)] bioassay, respectively (TSI vs Immulite P < .0025, TSI vs Cobas P < .0009). Fifteen newly diagnosed GD patients were all positive in the TSI bioassay, but only 11 (73%) were positive in the Cobas and Immulite binding assays. Nine GD patients with biochemical subclinical hyperthyroidism were TSI-positive but Immulite- and Cobas-negative. Two GD patients were blocking TSH-R-Ab [thyroid-blocking immunoglobin (TBI)]-positive and TSI-negative, and the Immulite and Cobas were positive in both. Additional serum samples from AITD patients that consisted of 30 TBI-positive and 10 TSI-positive samples were blindly tested in the binding assays. Only 6 of the 10 TSI-positive samples were positive in both binding assays, and 30 and 28 of the TBI-positive samples were positive in the Cobas and Immulite assays, respectively.
Conclusion
Binding TSH-R-Ab assays are less sensitive than TSI bioassays and are not specific for stimulating antibodies. Measuring the function of TSH-R-Ab in a bioassay can provide useful information to clinicians.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Thyroid & Endocrine Center of Florida, Sarasota, FL 34239, USA.
- Department of Microbiology and Molecular Pathogenesis, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Molecular Thyroid Research Laboratory, Department of Medicine I, Johannes Gutenberg-University Medical Center, Mainz 55131, Germany.
ORCID-Profile: Mark A Lupo, George J Kahaly
Förderung
- QuidelOrtho Corp
Zitieren
APA
Lupo, M. A., Olivo, P. D., Luffy, M., Wolf, J., & Kahaly, G. J. (2025). US-based, Prospective, Blinded Study of Thyrotropin Receptor Antibody in Autoimmune Thyroid Disease. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae448
Vancouver
Lupo MA, Olivo PD, Luffy M, Wolf J, Kahaly GJ. US-based, Prospective, Blinded Study of Thyrotropin Receptor Antibody in Autoimmune Thyroid Disease. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae448
BibTeX
@article{Lupo2025,
author = {Lupo, Mark A and Olivo, Paul D and Luffy, Maximilian and Wolf, Jan and Kahaly, George J},
title = {US-based, Prospective, Blinded Study of Thyrotropin Receptor Antibody in Autoimmune Thyroid Disease},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgae448}
}
EUVIMED